Moss N R, Maassen I, Billingy N E, Becker-Commissaris A, Hermens R, Broeders M, Walraven I
IQ Health Scientific Department, Raboud University Medical Center, Kapittelweg 54, Nijmegen, 6525 EP, Gelderland, The Netherlands.
Department of Pulmonology, Amsterdam University Medical Center, De Boelelaan 1118, Amsterdam, 1081 HZ, Noord-Holland, The Netherlands.
Support Care Cancer. 2025 Sep 4;33(10):833. doi: 10.1007/s00520-025-09868-x.
The shortage of healthcare professionals alongside the rising number of lung cancer survivors poses a significant challenge to current healthcare facilities. Risk-stratified follow-up care, with tailored diagnostic imaging and follow-up intervals based on a patients' risk of recurrence, may improve clinical outcomes and help address this challenge. Our study is aimed at identifying patient-perceived barriers and facilitators for implementing this approach.
A qualitative study was performed including 15 semi-structured interviews and three focus groups (n = 16) among lung cancer patients who completed treatment and currently receive follow-up care. Inductive and axial coding of the transcripts was performed to categorize codes into barriers and facilitators at six different levels using the Grol and Wensing framework.
Most barriers were identified at the organizational, economic, and political levels when shortening follow-up intervals and altering the imaging modalities due to limited available personnel, restricted imaging logistics, and financial resources. At the patient level, the most important barrier is fear of recurrence when extending follow-up intervals. Facilitators at the organizational level involved providing a direct point of contact and supportive care during risk-stratified follow-up. Overall, patients are willing to adopt risk-stratified follow-up care when sufficient evidence for its effectiveness is provided.
We found most of the barriers, facilitators, and preferences at the organizational, economic, political, and patient level. The identified barriers and facilitators in this study can serve as a base for a strategy to implement a risk-stratified follow-up care in lung cancer care if effectiveness can be proven.
医疗保健专业人员短缺,同时肺癌幸存者数量不断增加,这给当前的医疗保健机构带来了重大挑战。基于风险分层的后续护理,根据患者的复发风险定制诊断成像和随访间隔,可能会改善临床结果并有助于应对这一挑战。我们的研究旨在确定患者对实施这种方法的感知障碍和促进因素。
进行了一项定性研究,对15名完成治疗并目前正在接受后续护理的肺癌患者进行了半结构化访谈,并开展了三个焦点小组(共16人)。使用格罗尔和温辛框架对访谈记录进行归纳和轴心编码,将编码在六个不同层面归类为障碍和促进因素。
由于可用人员有限、成像后勤受限和财政资源有限,在缩短随访间隔和改变成像方式时,大多数障碍是在组织、经济和政治层面发现的。在患者层面,延长随访间隔时最重要的障碍是对复发的恐惧。组织层面的促进因素包括在基于风险分层的随访期间提供直接联系点和支持性护理。总体而言,当提供足够的有效性证据时,患者愿意采用基于风险分层的后续护理。
我们在组织、经济、政治和患者层面发现了大多数障碍、促进因素和偏好。如果有效性能够得到证明,本研究中确定的障碍和促进因素可作为在肺癌护理中实施基于风险分层的后续护理策略的基础。